Pancreas News and Research RSS Feed - Pancreas News and Research

The pancreas is a gland organ in the digestive and endocrine system of vertebrates. It is both an endocrine gland producing several important hormones, including insulin, glucagon, and somatostatin, as well as an exocrine gland, secreting pancreatic juice containing digestive enzymes that pass to the small intestine. These enzymes help in the further breakdown of the carbohydrates, protein, and fat in the chyme.
Family members of CUP patients at higher risk of developing CUP themselves

Family members of CUP patients at higher risk of developing CUP themselves

Cancer usually begins in one location and then spreads, but in 3 percent to 5 percent of cancer patients, the tissue where a cancer begins is unknown. In these individuals a cancer diagnosis is made because it has metastasized to other sites. Patients with these so-called "cancers of unknown primary," or CUP, have a very poor prognosis, with a median survival of three months. [More]
ACS, Alliance begin work on second volume of manual for cancer surgery

ACS, Alliance begin work on second volume of manual for cancer surgery

The American College of Surgeons and the Alliance for Clinical Trials in Oncology announced that they have begun work on the second volume of a comprehensive, evidence-based examination of cancer surgery techniques and recommendations. [More]
AGA issues six new clinical practice guidelines

AGA issues six new clinical practice guidelines

In 2015, the American Gastroenterological Association issued six clinical practice guidelines, all published in AGA's official journal Gastroenterology, offering current, evidence-based point-of-care recommendations to guide physicians at the bedside. [More]
Racial disparities exist for black and Hispanic patients undergoing major surgeries in U.S. hospitals

Racial disparities exist for black and Hispanic patients undergoing major surgeries in U.S. hospitals

Considerable racial disparities exist in surgical outcomes for black and Hispanic patients undergoing major cancer and non-cancer surgeries in U.S. hospitals, even among institutions that have already enrolled in a national surgical quality improvement initiative. [More]
TSRI scientists use new drug discovery technique to identify anti-diabetes compound

TSRI scientists use new drug discovery technique to identify anti-diabetes compound

Scientists from The Scripps Research Institute have deployed a powerful new drug discovery technique to identify an anti-diabetes compound with a novel mechanism of action. [More]
Gallstones, statins increase risk of acute pancreatitis, shows study

Gallstones, statins increase risk of acute pancreatitis, shows study

Idiopathic pancreatitis is often caused by small gallstones that are difficult to observe prior to surgery, shows a study from the University of Eastern Finland. Small gallstones were found in surgery from two out of three idiopathic pancreatitis patients. [More]
Purdue researchers develop products and processes to improve detection, treatment of diabetes

Purdue researchers develop products and processes to improve detection, treatment of diabetes

Food gatherings at Thanksgiving and Christmas require rigorous management by people affected by diabetes. Type 1 diabetes, also known as juvenile diabetes, is the result of the breakdown of insulin-producing cells in the pancreas. Type 2 diabetes can be the result of a combination of obesity, high caloric intake and a sedentary lifestyle. [More]
Experimental drug may stop life-threatening muscle wasting associated with advanced cancers

Experimental drug may stop life-threatening muscle wasting associated with advanced cancers

New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health. The experimental agent, known as AR-42 while in testing, was developed and tested in preclinical studies at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. [More]
New collaboration aims to develop novel generation artificial pancreas

New collaboration aims to develop novel generation artificial pancreas

Debiotech SA, the ARTORG Center for Biomedical Engineering Research of the University of Bern - and the Division of Endocrinology, Diabetes and Clinical Nutrition of the Bern University Hospital "Inselspital" are proud to announce the start of an exclusive collaboration to develop a novel generation artificial pancreas. [More]
Findings could offer doctors new method to diagnose pancreatic cancer earlier in patients

Findings could offer doctors new method to diagnose pancreatic cancer earlier in patients

By collecting samples from the portal vein--which carries blood from the gastrointestinal tract, including from the pancreas, to the liver--physicians can learn far more about a patient's pancreatic cancer than by relying on peripheral blood from a more easily accessed vein in the arm. [More]
Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers

Simple microRNA sensor holds promise for prognosis, treatment of pancreatic and other cancers

A simple, ultrasensitive microRNA sensor developed and tested by researchers from the schools of science and medicine at Indiana University-Purdue University Indianapolis and the Indiana University Melvin and Bren Simon Cancer Center holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers. [More]
New RNA test of blood platelets can be used to detect location of cancer

New RNA test of blood platelets can be used to detect location of cancer

A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood. Using this new method for blood-based RNA tests of blood platelets, researchers have been able to identify cancer with 96 per cent accuracy. This according to a study at Umeå University in Sweden recently published in the journal Cancer Cell. [More]
Betalin launches new EMP technology that could transform diabetes treatment

Betalin launches new EMP technology that could transform diabetes treatment

Betalin Therapeutics, a biotech company specializing in tissue engineering for curing diabetes, introduces the Engineered Micro Pancreas (EMP), a novel technology that provides significant levels of glucose-regulated insulin secretion over extended periods of time. [More]
Scientists discover small molecule that can block growth of BRCA-deficient cancer cells

Scientists discover small molecule that can block growth of BRCA-deficient cancer cells

Cancer cells with mutations in BRCA1 or BRCA2 genes, which serve a vital role in preserving the integrity of the genetic code, are key targets for cancer therapeutics. Yet, few agents can selectively eliminate cells deficient in BRCA, and none can do so without the risk of inducing drug resistance. [More]
Sleep loss reduces insulin sensitivity, increases diabetes risk

Sleep loss reduces insulin sensitivity, increases diabetes risk

A new study by the University of Colorado shows that the longer people are awake during the time their biological clock is telling them to sleep the worse their sensitivity to insulin, which is a precursor to diabetes. [More]
Accuray announces installation of CyberKnife M6 and TomoTherapy Systems at FALP Cancer Institute in Chile

Accuray announces installation of CyberKnife M6 and TomoTherapy Systems at FALP Cancer Institute in Chile

Accuray Incorporated announced today that the first CyberKnife M6 and TomoTherapy Systems in Chile are now installed at Fundacion Arturo Lopez Perez (FALP) Cancer Institute in Santiago, Chile. FALP is also the first hospital in Latin America to install both Accuray systems. [More]
Higher insulin levels linked to worse prognosis in advanced breast cancer

Higher insulin levels linked to worse prognosis in advanced breast cancer

Patients with breast cancer that has spread to other parts of the body (metastasised) and who have higher insulin levels than normal, but are not diabetic, have a significantly worse prognosis compared with those with normal insulin levels, a researcher will tell the Advanced Breast Cancer Third International Consensus Conference tomorrow (Friday). [More]
Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

Addressing quality of life needs in prostate cancer: an interview with Professor Louis Denis

Modern patient-directed management is based on optimal, individual medical treatment and holistic personalised patient-centred care. This is certainly true in prostate cancer where most patients are over 60 years of age. They face a negative physical and functional impact from the diagnosis as well as from the treatment with emotional and social challenges. [More]
New clinical trial uses aggressive treatment method for patients with pancreas cancer

New clinical trial uses aggressive treatment method for patients with pancreas cancer

Pancreas cancer remains one of the deadliest cancers worldwide. In the United States, it accounts for only three percent of all diagnosed cancers but it causes almost seven percent of all cancer deaths. A pancreas cancer diagnosis often comes after age 50 and after the cancer has spread, making it difficult to remove surgically. [More]
UCLA study finds cost variation across entire care process for low-risk prostate cancer

UCLA study finds cost variation across entire care process for low-risk prostate cancer

Now, for the first time, UCLA researchers have described cost across an entire care process for low-risk prostate cancer - from the time a patient checks in for his first appointment to his post-treatment follow-up testing - using time-driven activity-based costing. And they found a wide variation in costs for the various available treatments that remained consistent over a 12-year period, indicating a better method to monitor costs could save valuable healthcare dollars, said study first author Dr. Aaron Laviana, a fifth year urology resident. [More]
Advertisement
Advertisement